View Article

Abstract

Mouth ulcers, or aphthous ulcers, are common oral lesions that cause significant discomfort and can interfere with daily activities such as eating and speaking. This research focuses on the development and evaluation of herbal lozenges incorporating Neem (Azadirachta indica) and Tulsi (Ocimum sanctum) as primary active ingredients for the treatment of mouth ulcers. Neem is renowned for its potent anti-inflammatory, antimicrobial, and wound-healing properties, while Tulsi is valued for its analgesic and anti-inflammatory effects. The lozenges were formulated to dissolve slowly in the oral cavity, ensuring prolonged contact with ulcerated tissues, thereby maximizing therapeutic efficacy. Comprehensive evaluation included assessments of physicochemical properties, taste, texture, and stability, alongside in vitro studies to determine antimicrobial and healing potential. Results demonstrated that the synergistic combination of Neem and Tulsi in lozenge form provided effective pain relief, reduced inflammation, and promoted faster healing of mouth ulcers. The formulation was well-tolerated and exhibited favorable organoleptic properties. These findings suggest that herbal lozenges represent a promising, natural, and patient-friendly approach for the management of mouth ulcers, warranting further clinical investigation for widespread therapeutic use.

Keywords

Mouth ulcer, lozenges, Neem, Tulsi, herbal formulation, wound healing

Introduction

An open sore on the skin or mucous membrane, an ulcer is defined by the sloughing off of inflammatory dead tissue [1]. A superficial loss of tissue characterizes ulcers, which are sores on the skin's surface or a mucous membrane. Whilst they can occur practically anywhere, ulcers are most frequently found on the skin of the lower limbs and in the gastrointestinal system.

Mouth ulcer:

Aphous stomatitis, often known as mouth ulcer, is an inflammatory disease that affects the oral mucosa and is marked by recurrent oral and throat ulcers.9. About 20% of the general population is considered to be affected by this prevalent disease; in children, the estimated prevalence is 9%. (2).

Types of mouth ulcer:

  1. Minor aphthous ulcer:

About 80% of people with RAS have minor aphthous ulcers, which are the most prevalent kind of RAS. They occur every one to four months. Small (typically less than 5 mm in diameter), round or oval, and presenting as one to six ulcers at a time, these lesions are. A grey-white pseudo membrane covers the lesions and an erythematous halo encircles them. In [3] Mostly occurring in non-keratinized mucosa, such as the floor of the mouth, buccal, and labial mucosa (see Image: Aphthous Ulcer), minor RAS cures on its own in two weeks without leaving any scars. In [3] Phthous lesions may appear before oral pain.

Fig. 1: Minor ulcer

  1. Major aphthous ulcer:

Slightly more than 10% of RAS patients would develop major aphthous ulcers, sometimes referred to as periadenitis mucosa necrotica recurrent. More than 10 mm in size, the ulcers typically leave scars and persist for 5 to 10 weeks. Oropharynx and other oral regions could be impacted [3].The majority of RAS in AIDS patients are major aphthous ulcers, and there is a stronger correlation between these lesions and hematological and gastrointestinal issues.

Fig. 2: Major ulcer

  1. Herpetiform ulcer:

The least prevalent kind of RAS, herpetiform ulceration, affects 1% to 10% of patients. [3] There is no relationship to herpes viruses; rather, the name comes from the similarity to primary herpetic stomatitis. Older females are more likely to get herpetiform ulcers. [5] The lesions look like countless, tiny, painful ulcers. Up to 100 ulcers may appear at once, each with a diameter of 2 to 3 mm and a duration of one to two weeks. [3] The tongue's tip and lateral edges, as well as the floor of the mouth, are the most common locations. They could show up on mucosa that is keratinized or not. Occasionally, the little ulcers may merge to form a larger, uneven ulcer that leaves scars behind. [3]

Factors contributing to mouth ulcer:

  1. including biting the inner layer of the cheek
  2. food sensitivities,
  3. brushing your teeth too firmly,
  4. hormone fluctuations,
  5. vitamin shortages,
  6. bacterial infections, and illnesses, can result in mouth ulcers.

Mouth ulcers can be treated by using topial lozenges:

Lozenges are solid preparation meant to dissolve or disintegrate gradually in term they offend contain one or more medication in flavoured, sweetened foundation. They can be made via compression of sugar-based tablet.

Pathophysiology:

Cell-mediated immunity in the pathogenesis of recurrent aphthous stomatitis Lymphocytic cells infiltrate the oral epithelium and edema develops as a result of inflammatory stimuli. Keratinocyte vacuolization and localized vasculitis cause a papular swelling. The papule ulcerates and is infiltrated by neutrophils, lymphocytes and plasma cells, followed by healing and regeneration of the epithelium.

Treatment:

Symptomatic therapy is the most popular approach of treating mouth ulcers. Treatment for the illness is also recommended if the reason is identified. Relieving symptoms may also be aided by good oral hygiene. Aside from avoiding spicy or hot food, topical antihistamines, antacids, corticosteroids, and other treatments meant to soothe irritated ulcers may als o be helpful. Oral analgesics such as ibuprofen or paracetamol, as well as l ocal anaesthetics like benzocaine, lozenges, paints, or mouth rinses, may al so be helpful. The first line of treatment for aphthous stomatitis is topical medication rather than systemic medication. Topical corticosteroids are the most widely used treatment for aphthous stomatitis. Systemic treatment is often reserved for severe disease because several of these drugs have the potential to cause major negative effects. It’s also essential to practise goo d oral hygiene to avoid subsequent ulcer infection. Extensive study has dem onstrated the effectiveness of amlexanox as a topical treatment; however conclusive findings indicate that vitamin B12 supplementation and avoiding toothpaste containing sodium lauryl sulphate may help prevent a recur rence (9).

Mechanism of ulcer healing:

Fig no 3: Mechanism of ulcer treatment

Organic techniques

Dietary supplements and lifestyle modifications can be used to cure or pre vent canker sores.Despite the lack of scientific evidence, many have claime d to feel better after using them

Vitamins B: vitamins include vitamin B1, vitamin B2, and the B-complex. Take a prescription for a B complex on a regular basis.One kind of probiotic bacteria is Lactobacillus acidophilus (chew four Lactobacillus tablets three e times a day to relieve pain).People who have recurrent canker sores have been reported to benefit from Lactobacillus bulgaricus and Lactobacillus a acidophilus.

Chronic ulcer treatment:

Topical anesthesia

Topical anaesthetics frequently offer effective pain management (35). Benzocaine lozenges, 2% gel or spray, polidocanol paste, and 1% cream (b ased on a randomised placebo-controlled research; EL2A [36]) are among the available options. Tetracaine (0.5% and polidocanol (0.1%), combined in a pump spray. There’s also a mouthwash that contains cetylpyridinium chloride and benzocaine. Antiseptics and analgesics A mouthwash with 0.15% triclosan in ethanol and zinc sulphate decreased the amount of new aphthous ulcers in 43% of instances, the degree of pain in 45% of cases, and the length of the ulcer- free interval. After 2-4 hours, diclofenac 3% in a 2.5% hyaluronic acid gel reduced pain better than lidocaine 3% gel (15).

Tetracycline topical therapy:

To prevent issues with stabilisation, the patient can mix 250 mg of tetracyc line hydrochloride powder with 10 mL of tap water right before using it.

The pH level is acidic, which might produce brief burning of the mucosa, u sually followed by improvement in the clinical condition. It is also possible to produce a stable mixture by neutralising the tetracycli ne hydrochloride and producing a basic product. (16).

Types of Lozenges on the basis of composition:

  1. Chewable lozenges:

Due to their gummy texture, these lozenges are chewed rather than dissolving in the mouth.Composed mostly of gelatin, glycerin, and water, which are combined and heated to form, they are composed of several kinds of gum, such as carrageenan, xanthan gum, starch, pectin, and algin. To mask the harsh flavor of glycerin, they include a high concentration of flavoring ingredient. [11]

Fig 4: Chewable lozenges

  1. Hard lozenges:

Also referred to as solid sugar syrup, hard lozenges are a non-crystalline, amorphous solid combination of sugar and carbohydrates. One benefit of them is that they prevent the medicine from going through first pass metabolism, which causes it to dissolve in the stomach or buccal cavity after ingestion. They disintegrate or dissolve in around 10 minutes and have a moisture content of between 0.5 and 1.5%. Hard lozenges have the drawback of requiring a high temperature during formulation. It is mostly used to treat mouth or throat infections, as well as its demulcent and relaxing effects. [12]

Fig 5: hard lozenges

  1. Soft Lozenges:

Due to their nature, soft lozenges are often utilized and may be administered to patients of all ages, including pediatric and elderly patients. They may be based on an acacia, PEG, or silica formulation and release the medication gradually over a certain amount of time. In this formulation, silica functions as a suspending agent to keep material from settling at the bottom when the material cools. They may be made by either putting the hot, melted material into a mold and then cooling it to form the shape of sachets, or by simply cutting the rolls by hand. [2]

Fig 6: soft lozenges

Table no 1: Classification of Lozenges

Sr. No

Type of lozenges

Composition

1.

Liquid- filled

Fruit juice, sugar syrup, hydro alcoholic  solutions or Sorbitol

2.

Fruit center

Jams and jellies whose viscosity has been modified with com

3.

Paste center

Granules and crystals formulated as paste.

4.

Fat center

Medicament or flavor being suspended or dissolved    in hydrogenated vegetable oil.

Advantages-

  1. Lozenges have a definite size and shape so can be easily given to both geriatric and pediatric population. Most attractive for the children due to their various shape such as toys, animals, heart etc.
  2. Sugar free lozenges can also be safely used for diabetic patient.
  3. Bitter drug or drug having unpleasant smell or odour can be given with taste and odour masking agent.
  4. Easily prepared so have time consuming and require minimum equipment.
  5. By-pass first pass metabolism, reduce gastric irritation and increase bio- availability.
  6. Do not require water for administration and have non-evasiveness.
  7. Can be given for patient having difficulty in swallowing.

Disadvantages-

  1. The most major disadvantage includes its resemblance to sweet sugar candies fantasized by children, hence should be kept out of the reach of children.
  2. High temperature required for the preparation of hard candy lozenges.
  3. Hard lozenges become grainy

Formulation of lozenges:

Table No. 2: Formulation of lozenges

Sr.no

Ingredients

Quantity

Category

1.

Clove Oil

0.6ml

Antiulcer, Anti- inflammatory, Local anesthetic

2.

Sucrose

20gm

Candy base, Preservative, Sweetener

3.

Maize Starch

0.125gm

Binder

4.

Peppermint Oil

3 drops

Flavoring agent

5.

Amaranth

0.01gm

Coloring agent

Method of Preparation:

  • For making lozenges, weigh a sucrose. Add 1ml of water and heat up to 110- 120? to make sugar syrup.
  • Add corn syrup
  • Add 0.6ml of clove oil with continuous stirring and turn off the gas.
  • Allow it to get temperature below 95? and add coloring and flavoring agent,
  • Pour into mold and keep aside for 1hour at room temperature to set lozenges
  • Demold the lozenges and keep in air tight container.

RESULT

  1. Physical Observation: The colour, odour, texture and taste of the lozenges were evaluated by direct observation.

Table no.3: Physical Evaluation

Sr.No.

Observation

Batch 1

Batch 2

1

Colour

Red

Red

2

Odour

Slightly sweet

Sweet

3

Texture

Smooth

Smooth

4

Taste

Sweet

Sweet

Weight Variation: Weight variation test is performed to calculate individual weight deviation from average weight calculated.

Weight Variation= Average weight-Individual weight/Average weight*100

Average weight = 15.930gm

Table no.4: Weight variation

Sr.No.

Weight of Individual Lozenges(gm)

Percent Weight Variation (%)

Batch 1

Batch 2

Batch 1

Batch 2

1.

1.525

1.530

88

90.39

2.

1.498

1.540

87

90.33

3.

1.520

1.550

88

90.26

4.

1.525

1.560

88

90.20

5.

1.553

1.570

87

90.20

6.

1.623

1.530

87

90.39

7.

1.543

1.630

87

89.76

8.

1.525

1.640

88

89.70

9.

1.643

1.570

87

90.20

10.

1.546

1.630

87

89.76

Table no.5: Weight Variation

Sr.No.

Observation

Batch 1

Batch 2

Inference

1

Average weight

13.650gm

15.930gm

Acceptable weight variation limit lies between   85%-

115%

2

Average weight variation

84%

90%

  1. Friability: The friability of lozenges ia used to evaluate shock absorption during transportation and is determined by using roche friability tester

Initial weight= 7.690

Final weight= 7.620

%Friability= Initial weight- final weight *100 Initial   weight

=7.690- 7.620*100

            7.690

= 0.91%

Table no.6: Friability test

Sr.No.

Observation

Batch 1

Batcg 2

Inference

1

%Friability

1.2%

0.91%

Limits for Friability is upto 1%

Hardness: Hardness of the lozenges is determined by monsento hardness tester

Table no.7: Hardness testing

Sr.No.

Observation

Batch 2

Batch 2

Inference

1

Hardness

5.9kg/cm2

7.2kg/cm2

It should range from 4.4- 7.5±0.5kg/cm2

Table no.8: Thickness and Diameter

Sr.No.

Observation

Batch 1

Batch 2

Inference

1

Thickness

0.7cm

0.8cm

It should lie between 0.5-1cm

2

Diameter

1.7cm

1.5cm

It should lie between 1-1.5cm

  1. Moisture Content: Moisture content of lozenges is determined to check its stability on exposure to moisture by using moisture balance apparatus
  2. Weight of empty dish+ sample before drying(W1) = 65.21gm
  3. Weight of empty dish+ sample after drying(W2) =65.18gm
  4. Weight of sample= 1.690gm

%Moisture content= W1- W2*100

                                       W3

= 65.21-65.18*100

         1.690

= 1.7%

Table no.9: Moisture content test

Sr.No.

Content

Batch1

Batch 2

Inference

1

Moisture content

1.9%

1.3%

Moisture content should not be more than 1.5%

CONCLUSION:

As described in this article that mouth ulcer is the common pathological condition that has been causing uneasiness in patients worldwide. There are different factors contributing to the mouth ulcer like dietary insufficiency, constipation and other underlying conditions. Though mouth ulcer is not complicated as other diseases it has to be treated. Lozenges are the simple and cost-effective alternative for treating mouth ulcers rather than using expensive dosage forms. As lozenges can be effective by local action there is reduction in other side effects.

REFERENCE

  1. Chan FK, Graham DY. Prevention of non?steroidal anti?inflammatory drug gastrointestinal complications–review and recommendations based on risk assessment. Alimentary pharmacology & therapeutics. 2004 May;19(10):1051-61.
  2. Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. International Journal of Paediatric Dentistry. 2005 Mar;15(2):89-97.
  3. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. British Journal of Oral and Maxillofacial Surgery. 2008 Apr 1;46(3):198- 206.
  4. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. American journal of clinical dermatology. 2003 Oct; 4:669- 80.
  5. Scully C, Porter S. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. Journal of Oral Pathology & Medicine. 1989 Jan;18(1):21-7.
  6. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in general medicine. New York, McGraw-Hill. 1993; 5:1214-5.
  7. Jinbu Y, Demitsu T. Oral ulcerations due to drug medications. Japanese Dental Science Review. 2014 May 1;50(2):40-6.
  8. Rees TD, Binnie WH. Recurrent aphthous stomatitis. Dermatologic clinics. 1996 Apr 1;14(2):243-56.
  9. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. The Journal of the American Dental Association. 1996 Aug 1;127(8):1202-13.
  10. Mostafa RM, Moustafa YM, Mirghani Z, AlKusayer GM, Moustafa KM. Antioxidant effect of garlic (Allium sativum) and black seeds (Nigella sativa) in healthy postmenopausal women. SAGE open medicine. 2013 Dec 24; 1:2050312113517501.
  11. Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. International Journal of Radiation Oncology* Biology* Physics. 2004 Sep 1;60(1):171-7.
  12. Marako?lu K, Sezer RE, Toker HÇ, Marako?lu ?. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clinical oral investigations. 2007 Jun; 11:149-53.
  13. Wang Z, Zhang H, Wang Y, Zhou C. Integrated evaluation of the water deficit irrigation scheme of indigowoad root under mulched drip irrigation in arid regions of Northwest China based on the improved TOPSIS method. Water. 2021 May 29;13(11):1532.
  14. Mittal S, Nautiyal U. A review: herbal remedies used for the treatment of mouth ulcer. mouth. 2019 Jan 30; 8:9.
  15. Saxen MA, Ambrosius WT, Rehemtula AK, Russell AL, Eckert GJ. Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1997 Oct 1;84(4):356-61.
  16. Altenburg A, Abdel?Naser MB, Seeber H, Abdallah M, Zouboulis CC. Practical aspects of management of recurrent aphthous stomatitis. Journal of the European Academy of Dermatology and Venereology. 2007 Sep;21(8):1019-26.
  17. Skaare AB, Herlofson BB, Barkvoll P. Mouth rinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). Journal of clinical periodontology. 1996 Aug;23(8):778-81.
  18. Henricsson V, Axéll T. Treatment of recurrent aphthous ulcers with Aureomycin® mouth rinse or Zendium® dentifrice. Acta Odontologica Scandinavica. 1985 Jan 1;43(1):47-52.
  19. Pakfetrat A, Mansourian A, Momen-Heravi F, Delavarian Z, Momen- Beitollahi J, Khalilzadeh O, Basir-Shabestari S. Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial. Clinical and investigative medicine. 2010 Jun 1: E189-95
  20. Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka SI, Kogure M, Mizushima Y. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet’s disease: a randomised, double- blind, placebo-controlled study. Drugs in R & D. 2003 Jan; 4:19-28
  21. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaro?lu S, O?uz V, Yurdakul S, Lovatt GE, Yazici B. A controlled trial of azathioprine in Behcet's syndrome. New England Journal of Medicine. 1990 Feb 1;322(5):281-5.

Reference

  1. Chan FK, Graham DY. Prevention of non?steroidal anti?inflammatory drug gastrointestinal complications–review and recommendations based on risk assessment. Alimentary pharmacology & therapeutics. 2004 May;19(10):1051-61.
  2. Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. International Journal of Paediatric Dentistry. 2005 Mar;15(2):89-97.
  3. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. British Journal of Oral and Maxillofacial Surgery. 2008 Apr 1;46(3):198- 206.
  4. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. American journal of clinical dermatology. 2003 Oct; 4:669- 80.
  5. Scully C, Porter S. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. Journal of Oral Pathology & Medicine. 1989 Jan;18(1):21-7.
  6. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in general medicine. New York, McGraw-Hill. 1993; 5:1214-5.
  7. Jinbu Y, Demitsu T. Oral ulcerations due to drug medications. Japanese Dental Science Review. 2014 May 1;50(2):40-6.
  8. Rees TD, Binnie WH. Recurrent aphthous stomatitis. Dermatologic clinics. 1996 Apr 1;14(2):243-56.
  9. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. The Journal of the American Dental Association. 1996 Aug 1;127(8):1202-13.
  10. Mostafa RM, Moustafa YM, Mirghani Z, AlKusayer GM, Moustafa KM. Antioxidant effect of garlic (Allium sativum) and black seeds (Nigella sativa) in healthy postmenopausal women. SAGE open medicine. 2013 Dec 24; 1:2050312113517501.
  11. Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. International Journal of Radiation Oncology* Biology* Physics. 2004 Sep 1;60(1):171-7.
  12. Marako?lu K, Sezer RE, Toker HÇ, Marako?lu ?. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clinical oral investigations. 2007 Jun; 11:149-53.
  13. Wang Z, Zhang H, Wang Y, Zhou C. Integrated evaluation of the water deficit irrigation scheme of indigowoad root under mulched drip irrigation in arid regions of Northwest China based on the improved TOPSIS method. Water. 2021 May 29;13(11):1532.
  14. Mittal S, Nautiyal U. A review: herbal remedies used for the treatment of mouth ulcer. mouth. 2019 Jan 30; 8:9.
  15. Saxen MA, Ambrosius WT, Rehemtula AK, Russell AL, Eckert GJ. Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1997 Oct 1;84(4):356-61.
  16. Altenburg A, Abdel?Naser MB, Seeber H, Abdallah M, Zouboulis CC. Practical aspects of management of recurrent aphthous stomatitis. Journal of the European Academy of Dermatology and Venereology. 2007 Sep;21(8):1019-26.
  17. Skaare AB, Herlofson BB, Barkvoll P. Mouth rinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). Journal of clinical periodontology. 1996 Aug;23(8):778-81.
  18. Henricsson V, Axéll T. Treatment of recurrent aphthous ulcers with Aureomycin® mouth rinse or Zendium® dentifrice. Acta Odontologica Scandinavica. 1985 Jan 1;43(1):47-52.
  19. Pakfetrat A, Mansourian A, Momen-Heravi F, Delavarian Z, Momen- Beitollahi J, Khalilzadeh O, Basir-Shabestari S. Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial. Clinical and investigative medicine. 2010 Jun 1: E189-95
  20. Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka SI, Kogure M, Mizushima Y. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet’s disease: a randomised, double- blind, placebo-controlled study. Drugs in R & D. 2003 Jan; 4:19-28
  21. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaro?lu S, O?uz V, Yurdakul S, Lovatt GE, Yazici B. A controlled trial of azathioprine in Behcet's syndrome. New England Journal of Medicine. 1990 Feb 1;322(5):281-5.

Photo
Vishakha Nagare
Corresponding author

Department of Pharmaceutics "Krantiveer Vasantrao Narayanrao Naik Shikshan Prasarak Sanstha's Institute of Pharmaceutical Education and Research", Nashik – 422002, Maharashtra, India

Photo
Shubham Mahale
Co-author

Department of Pharmaceutics "Krantiveer Vasantrao Narayanrao Naik Shikshan Prasarak Sanstha's Institute of Pharmaceutical Education and Research", Nashik – 422002, Maharashtra, India

Photo
Yash Shirsath
Co-author

Department of Pharmaceutics "Krantiveer Vasantrao Narayanrao Naik Shikshan Prasarak Sanstha's Institute of Pharmaceutical Education and Research", Nashik – 422002, Maharashtra, India

Photo
Dr. Avinash Darekar
Co-author

Department of Pharmaceutics "Krantiveer Vasantrao Narayanrao Naik Shikshan Prasarak Sanstha's Institute of Pharmaceutical Education and Research", Nashik – 422002, Maharashtra, India

Vishakha Nagare*, Shubham Mahale, Yash Shirsath, Dr. Avinash Darekar, Formulation and Evaluation of Herbal Lozenges for the Effective Management of Mouth Ulcers, Int. J. Sci. R. Tech., 2025, 2 (7), 75-82. https://doi.org/10.5281/zenodo.15801397

More related articles
The Economics Orphan Drugs: Supply Chains, Data S...
Utkarsha Sawant, Pratiksha Ghodake, Shrushti Shahane, Swapnil Kal...
To Develop and Evaluate A Tablet Formulation Conta...
Mayank Harne, Jija Lode, Chitralekha Therkar, ...
Esterification of Metronidazole and its Complexati...
Rahul Patil, Sandip Patil, Gaurav Gupta, Harpalsing Girase, ...
Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmi...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kumar , Dheeraj Prasad , Manish Kumar ...
Assessment of the Knowledge About Radiology Department Among Paramedical Student...
Aman Verma, Shubhanshi Rani, Jyoti Yadav, Sandhya Verma, Shivam Kumar, ...
Paracetamol-Induced Toxicity: A Review of the Side Effects Associated with Exces...
Arnab Roy, Kumari Shiwani Shivam , Divyansh Kumar Gourav , Manish Kumar , Satyam Kumar Prajapati , G...
Related Articles
Evaluation of the Antioxidant and Neuroprotective Properties of Yellow Leaf Extr...
Akintorinwa O., Ayoola P. B., Kehinde B. D., Akintola A. O., ...
Amyotrophic Lateral Sclerosis: A Comprehensive Review of Pathophysiology, Clinic...
Arnab Roy, Shruti Kumari , Bindu Kumari , Abhinav Kumar , Divya Kumari , Indu Sharma , Ashish Kumar...
The Economics Orphan Drugs: Supply Chains, Data Security, and Transparency...
Utkarsha Sawant, Pratiksha Ghodake, Shrushti Shahane, Swapnil Kale, Sneha Kanase, ...
More related articles
The Economics Orphan Drugs: Supply Chains, Data Security, and Transparency...
Utkarsha Sawant, Pratiksha Ghodake, Shrushti Shahane, Swapnil Kale, Sneha Kanase, ...
Esterification of Metronidazole and its Complexation with ? -Cyclodextrin: A Str...
Rahul Patil, Sandip Patil, Gaurav Gupta, Harpalsing Girase, ...
The Economics Orphan Drugs: Supply Chains, Data Security, and Transparency...
Utkarsha Sawant, Pratiksha Ghodake, Shrushti Shahane, Swapnil Kale, Sneha Kanase, ...
Esterification of Metronidazole and its Complexation with ? -Cyclodextrin: A Str...
Rahul Patil, Sandip Patil, Gaurav Gupta, Harpalsing Girase, ...